Diabetic ketoacidosis treatment during COVID-19 pandemic in a country with scarce health resources

Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1847-1848. doi: 10.1016/j.dsx.2020.09.014. Epub 2020 Sep 11.

Authors

Claudia C Gutiérrez-Ortiz¹, Marcio J Concepción-Zavaleta², Eilhart J García-Villasante³

Affiliations

¹ Universidad Nacional Mayor de San Marcos, Division of Endocrinology, Hospital Nacional Daniel Alcides Carrion, Lima, Peru. Electronic address: cecilia_gut09@hotmail.com.
² Universidad Nacional Mayor de San Marcos, Division of Endocrinology, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
³ Universidad Nacional Mayor de San Marcos, Division of Endocrinology, Hospital Nacional Daniel Alcides Carrion, Lima, Peru.

No abstract available

Keywords: COVID-19; Diabetic ketoacidosis; Health resources.

Publication types

Letter

MeSH terms

COVID-19 / economics
COVID-19 / epidemiology*
Diabetic Ketoacidosis / drug therapy*
Diabetic Ketoacidosis / economics
Diabetic Ketoacidosis / epidemiology*
Health Resources / economics
Health Resources / trends*
Humans
Insulin / administration & dosage*
Insulin / economics
Pandemics

Substances

Insulin